Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593285837> ?p ?o ?g. }
- W2593285837 endingPage "655" @default.
- W2593285837 startingPage "648" @default.
- W2593285837 abstract "Objective/BackgroundFenestrated endovascular repair (FEVAR) has been used to treat complex abdominal aortic aneurysms (AAAs). The risk of renal function deterioration compared with infrarenal endovascular aortic repair (EVAR) has not been determined.MethodsPatients with preserved renal function (estimated glomerular filtration rate [eGFR] > 45 mL/minute) enrolled in two prospective, non-randomised studies evaluating Zenith fenestrated and AAA stent grafts were matched (1:2) by propensity scores for age, sex, hypertension, diabetes, and pre-operative eGFR. Sixty-seven patients were treated by FEVAR and 134 matched controls treated by EVAR. Mean follow-up was 30 ± 20 months. Outcomes included acute kidney injury (AKI) defined by RIFLE and changes in serum creatinine (sCr), eGFR, and chronic kidney disease (CKD) staging up to 5 years.ResultsAKI at 1 month was similar between groups, with > 25% decline in eGFR observed in 5% of FEVAR and 9% of EVAR patients (p = .39). There were no significant differences in > 25% decline in eGFR at 2 years (FEVAR 20% vs. EVAR 20%; p > .99) or 5 years (FEVAR 27% vs. EVAR 50%; p = .50). Progression to stage IV–V CKD was similar at 2 years (FEVAR 2% vs. EVAR 3%; p > .99) and 5 years (FEVAR 7% vs. EVAR 8%; p > .99), with similar sCr and eGFR up to 5 years. During follow-up, there were more renal artery stenosis/occlusions (15/67 [22%] vs. 3/134 [2%]; p < .001) and renal related re-interventions (12/67 [18%] vs. 4/134 [3%]; p < .001) in patients treated by FEVAR. Rate of progression to renal failure requiring dialysis was low and identical in both groups (1.5% vs. 1.5%; p > .99).ConclusionAortic repair with FEVAR and EVAR was associated with similar rates of renal function deterioration in patients with preserved pre-operative renal function. Renal related re-interventions were higher following FEVAR, although net changes in renal function were similar in both groups. Fenestrated endovascular repair (FEVAR) has been used to treat complex abdominal aortic aneurysms (AAAs). The risk of renal function deterioration compared with infrarenal endovascular aortic repair (EVAR) has not been determined. Patients with preserved renal function (estimated glomerular filtration rate [eGFR] > 45 mL/minute) enrolled in two prospective, non-randomised studies evaluating Zenith fenestrated and AAA stent grafts were matched (1:2) by propensity scores for age, sex, hypertension, diabetes, and pre-operative eGFR. Sixty-seven patients were treated by FEVAR and 134 matched controls treated by EVAR. Mean follow-up was 30 ± 20 months. Outcomes included acute kidney injury (AKI) defined by RIFLE and changes in serum creatinine (sCr), eGFR, and chronic kidney disease (CKD) staging up to 5 years. AKI at 1 month was similar between groups, with > 25% decline in eGFR observed in 5% of FEVAR and 9% of EVAR patients (p = .39). There were no significant differences in > 25% decline in eGFR at 2 years (FEVAR 20% vs. EVAR 20%; p > .99) or 5 years (FEVAR 27% vs. EVAR 50%; p = .50). Progression to stage IV–V CKD was similar at 2 years (FEVAR 2% vs. EVAR 3%; p > .99) and 5 years (FEVAR 7% vs. EVAR 8%; p > .99), with similar sCr and eGFR up to 5 years. During follow-up, there were more renal artery stenosis/occlusions (15/67 [22%] vs. 3/134 [2%]; p < .001) and renal related re-interventions (12/67 [18%] vs. 4/134 [3%]; p < .001) in patients treated by FEVAR. Rate of progression to renal failure requiring dialysis was low and identical in both groups (1.5% vs. 1.5%; p > .99). Aortic repair with FEVAR and EVAR was associated with similar rates of renal function deterioration in patients with preserved pre-operative renal function. Renal related re-interventions were higher following FEVAR, although net changes in renal function were similar in both groups." @default.
- W2593285837 created "2017-03-16" @default.
- W2593285837 creator A5043875322 @default.
- W2593285837 creator A5047493538 @default.
- W2593285837 creator A5051444081 @default.
- W2593285837 creator A5053554452 @default.
- W2593285837 creator A5055044637 @default.
- W2593285837 creator A5063900986 @default.
- W2593285837 creator A5067965279 @default.
- W2593285837 creator A5079447750 @default.
- W2593285837 creator A5089306278 @default.
- W2593285837 date "2017-05-01" @default.
- W2593285837 modified "2023-10-16" @default.
- W2593285837 title "Editor's Choice – Comparison of Renal Outcomes in Patients Treated by Zenith® Fenestrated and Zenith® Abdominal Aortic Aneurysm Stent grafts in US Prospective Pivotal Trials" @default.
- W2593285837 cites W1538756962 @default.
- W2593285837 cites W1798210137 @default.
- W2593285837 cites W1973535115 @default.
- W2593285837 cites W1978416919 @default.
- W2593285837 cites W1995113125 @default.
- W2593285837 cites W2006990154 @default.
- W2593285837 cites W2008637458 @default.
- W2593285837 cites W2012892976 @default.
- W2593285837 cites W2015684220 @default.
- W2593285837 cites W2018372305 @default.
- W2593285837 cites W2019753293 @default.
- W2593285837 cites W2028303801 @default.
- W2593285837 cites W2045272170 @default.
- W2593285837 cites W2047830531 @default.
- W2593285837 cites W2065239900 @default.
- W2593285837 cites W2066459511 @default.
- W2593285837 cites W2066506068 @default.
- W2593285837 cites W2083793872 @default.
- W2593285837 cites W2097903456 @default.
- W2593285837 cites W2102634195 @default.
- W2593285837 cites W2103140127 @default.
- W2593285837 cites W2110489896 @default.
- W2593285837 cites W2120684848 @default.
- W2593285837 cites W2133275623 @default.
- W2593285837 cites W2136309091 @default.
- W2593285837 cites W2136661270 @default.
- W2593285837 cites W2141573800 @default.
- W2593285837 cites W2144496388 @default.
- W2593285837 cites W2146327271 @default.
- W2593285837 cites W2146382330 @default.
- W2593285837 cites W2150291618 @default.
- W2593285837 cites W2151177051 @default.
- W2593285837 cites W2159474820 @default.
- W2593285837 cites W2169900605 @default.
- W2593285837 cites W2171546308 @default.
- W2593285837 cites W2215326043 @default.
- W2593285837 cites W2243156521 @default.
- W2593285837 cites W4242390842 @default.
- W2593285837 doi "https://doi.org/10.1016/j.ejvs.2017.02.005" @default.
- W2593285837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28285957" @default.
- W2593285837 hasPublicationYear "2017" @default.
- W2593285837 type Work @default.
- W2593285837 sameAs 2593285837 @default.
- W2593285837 citedByCount "34" @default.
- W2593285837 countsByYear W25932858372018 @default.
- W2593285837 countsByYear W25932858372019 @default.
- W2593285837 countsByYear W25932858372020 @default.
- W2593285837 countsByYear W25932858372021 @default.
- W2593285837 countsByYear W25932858372022 @default.
- W2593285837 countsByYear W25932858372023 @default.
- W2593285837 crossrefType "journal-article" @default.
- W2593285837 hasAuthorship W2593285837A5043875322 @default.
- W2593285837 hasAuthorship W2593285837A5047493538 @default.
- W2593285837 hasAuthorship W2593285837A5051444081 @default.
- W2593285837 hasAuthorship W2593285837A5053554452 @default.
- W2593285837 hasAuthorship W2593285837A5055044637 @default.
- W2593285837 hasAuthorship W2593285837A5063900986 @default.
- W2593285837 hasAuthorship W2593285837A5067965279 @default.
- W2593285837 hasAuthorship W2593285837A5079447750 @default.
- W2593285837 hasAuthorship W2593285837A5089306278 @default.
- W2593285837 hasBestOaLocation W25932858371 @default.
- W2593285837 hasConcept C126322002 @default.
- W2593285837 hasConcept C126894567 @default.
- W2593285837 hasConcept C141071460 @default.
- W2593285837 hasConcept C159641895 @default.
- W2593285837 hasConcept C166957645 @default.
- W2593285837 hasConcept C2776098176 @default.
- W2593285837 hasConcept C2776543907 @default.
- W2593285837 hasConcept C2776634560 @default.
- W2593285837 hasConcept C2777051993 @default.
- W2593285837 hasConcept C2778583881 @default.
- W2593285837 hasConcept C2778653478 @default.
- W2593285837 hasConcept C2779993416 @default.
- W2593285837 hasConcept C2780091579 @default.
- W2593285837 hasConcept C2780306776 @default.
- W2593285837 hasConcept C2781016617 @default.
- W2593285837 hasConcept C71924100 @default.
- W2593285837 hasConcept C95457728 @default.
- W2593285837 hasConceptScore W2593285837C126322002 @default.
- W2593285837 hasConceptScore W2593285837C126894567 @default.
- W2593285837 hasConceptScore W2593285837C141071460 @default.
- W2593285837 hasConceptScore W2593285837C159641895 @default.
- W2593285837 hasConceptScore W2593285837C166957645 @default.
- W2593285837 hasConceptScore W2593285837C2776098176 @default.